Unknown

Dataset Information

Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase.


ABSTRACT:

Background

Monitoring lower-grade gliomas (LrGGs) for disease progression is made difficult by the limits of anatomical MRI to distinguish treatment related tissue changes from tumor progression. MR spectroscopic imaging (MRSI) offers additional metabolic information that can help address these challenges. The goal of this study was to compare longitudinal changes in multiparametric MRI, including diffusion weighted imaging, perfusion imaging, and 3D MRSI, for LrGG patients who progressed at the final time-point and those who remained clinically stable.

Methods

Forty-one patients with LrGG who were clinically stable were longitudinally assessed for progression. Changes in anatomical, diffusion, perfusion and MRSI data were acquired and compared between patients who remained

SUBMITTER: Avalos LN 

PROVIDER: S-EPMC9721386 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature